Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Drugging the cancer stem cell compartment: lessons learned from the hedgehog and Wnt signal transduction pathways.

Dodge ME, Lum L.

Annu Rev Pharmacol Toxicol. 2011;51:289-310. doi: 10.1146/annurev-pharmtox-010510-100558. Review.

2.

Drug discovery approaches to target Wnt signaling in cancer stem cells.

Curtin JC, Lorenzi MV.

Oncotarget. 2010 Nov;1(7):552-66. Review.

3.

Targeting Hedgehog--a cancer stem cell pathway.

Merchant AA, Matsui W.

Clin Cancer Res. 2010 Jun 15;16(12):3130-40. doi: 10.1158/1078-0432.CCR-09-2846. Review.

4.

Small-molecule modulators of Hh and Wnt signaling pathways.

Kiselyov AS, Tkachenko SE, Balakin KV, Ivachtchenko AV.

Expert Opin Ther Targets. 2007 Aug;11(8):1087-101. Review.

PMID:
17665980
5.

Hedgehog signalling as a target in cancer stem cells.

Medina V, Calvo MB, Díaz-Prado S, Espada J.

Clin Transl Oncol. 2009 Apr;11(4):199-207. Review.

PMID:
19380296
6.

The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer.

Sarkar FH, Li Y, Wang Z, Kong D.

Cancer Metastasis Rev. 2010 Sep;29(3):383-94. doi: 10.1007/s10555-010-9233-4. Review.

7.

Targeting Wnt signaling: can we safely eradicate cancer stem cells?

Takahashi-Yanaga F, Kahn M.

Clin Cancer Res. 2010 Jun 15;16(12):3153-62. doi: 10.1158/1078-0432.CCR-09-2943. Review.

8.

The Hedgehog pathway as a drug target in cancer therapy.

Lauth M, Toftgård R.

Curr Opin Investig Drugs. 2007 Jun;8(6):457-61. Review.

PMID:
17621875
9.

Cancer stem cell epigenetics and chemoresistance.

Crea F, Danesi R, Farrar WL.

Epigenomics. 2009 Oct;1(1):63-79. doi: 10.2217/epi.09.4. Review.

PMID:
22122637
10.

Wnt signalling and cancer stem cells.

Espada J, Calvo MB, Díaz-Prado S, Medina V.

Clin Transl Oncol. 2009 Jul;11(7):411-27. Review.

PMID:
19574199
11.

Cancer stem cell and niche.

Nie D.

Front Biosci (Schol Ed). 2010 Jan 1;2:184-93. Review.

PMID:
20036939
12.

The Hedgehog and Wnt signalling pathways in cancer.

Taipale J, Beachy PA.

Nature. 2001 May 17;411(6835):349-54. Review.

PMID:
11357142
13.

Targeting embryonic signaling pathways in cancer therapy.

Harris PJ, Speranza G, Dansky Ullmann C.

Expert Opin Ther Targets. 2012 Jan;16(1):131-45. doi: 10.1517/14728222.2011.645808. Review.

PMID:
22239436
14.

[Novel signal transduction pathways: the molecular basis for targeted cancer therapies in Hedgehog/Notch/Wnt pathway].

Shimizu T, Nakagawa K.

Nihon Rinsho. 2015 Aug;73(8):1342-8. Review. Japanese.

PMID:
26281688
15.
16.

Targeting the Hedgehog pathway in cancer.

Rubin LL, de Sauvage FJ.

Nat Rev Drug Discov. 2006 Dec;5(12):1026-33. Review.

PMID:
17139287
17.

Targeting hedgehog in cancer stem cells: how a paradigm shift can improve treatment response.

Tung DC, Chao KS.

Future Oncol. 2007 Oct;3(5):569-74. Review.

PMID:
17927522
18.
19.

[Signal pathways in breast cancer stem cells and the targeted stem cell therapy].

Ma Y, Wang HX.

Zhonghua Zhong Liu Za Zhi. 2010 Dec;32(12):881-5. Review. Chinese. No abstract available.

PMID:
21223793
20.

Targeting Hedgehog signaling and understanding refractory response to treatment with Hedgehog pathway inhibitors.

Queiroz KC, Spek CA, Peppelenbosch MP.

Drug Resist Updat. 2012 Aug;15(4):211-22. doi: 10.1016/j.drup.2012.05.002. Review.

PMID:
22910179

Supplemental Content

Support Center